Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Other Events
29 Mar 24
8-K
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
23 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
8-K
Entry into a Material Definitive Agreement
21 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
19 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Oct 23
8-K
Entry into a Material Definitive Agreement
20 Apr 23
8-K
Other Events
29 Mar 23
8-K
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
24 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
30 Dec 22
Registration and prospectus
S-3/A
Shelf registration (amended)
6 Feb 24
S-3
Shelf registration
12 Jan 24
S-8
Registration of securities for employees
24 Oct 22
424B5
Prospectus supplement for primary offering
16 Dec 21
D
$5.25M in debt / options / securities to be acquired, sold $5.25M, 1 investor
29 Nov 21
S-3
Shelf registration
8 Jan 21
S-8
Registration of securities for employees
21 Dec 20
POS AM
Prospectus update (post-effective amendment)
3 Feb 10
S-3
Shelf registration
28 Dec 09
424B3
Prospectus supplement
1 Oct 09
Proxies
DEF 14A
Definitive proxy
7 Nov 23
PRE 14A
Preliminary proxy
27 Oct 23
DEF 14A
Definitive proxy
14 Nov 22
PRE 14A
Preliminary proxy
4 Nov 22
DEFA14A
Additional proxy soliciting materials
15 Nov 21
DEF 14A
Definitive proxy
15 Nov 21
DEFA14A
Additional proxy soliciting materials
16 Nov 20
DEF 14A
Definitive proxy
16 Nov 20
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEF 14A
Definitive proxy
6 Nov 19
Other
EFFECT
Notice of effectiveness
15 Feb 24
CORRESP
Correspondence with SEC
14 Feb 24
CORRESP
Correspondence with SEC
6 Feb 24
UPLOAD
Letter from SEC
25 Jan 24
UPLOAD
Letter from SEC
16 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
UPLOAD
Letter from SEC
27 Oct 23
CORRESP
Correspondence with SEC
18 Oct 23
UPLOAD
Letter from SEC
26 Sep 23
CORRESP
Correspondence with SEC
8 Sep 23